http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02097117-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e93326df31cf8cf73ab5dc89dda94a23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5e95156255d5fe8b2923c544786e176 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6475 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4747 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate | 2002-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5c6804e6297ad77dff78e09c12e4924 |
| publicationDate | 2002-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-02097117-A2 |
| titleOfInvention | Ipaf, an ice-protease activating factor |
| abstract | Ipaf nucleic acid molecules and encoded polypeptides are provided. Also provided are methods of using Ipaf polypeptides and nucleic acid molecules. The Invention also provides methodes of screening for inhibitors or enhancers of Ipaf-mediated apoptosis or procaspase-1 processing. The invention further provides production, isolation and purification of Ipaf polypeptides as well as antibodies against said polypeptides. In addition, the invention provides compositions of Ipaf polypeptides, anti-Ipaf antibodies, and/or Ipaf nucleic acid molecules that can be utilized for diagnostic or therapeutic purposes. |
| priorityDate | 2001-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 844.